Infertility Survey for Breast and Gynecological Cancers

JA
Overseen ByJose A Rauh-Hain
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how women who have survived gynecological or breast cancer consider having children post-treatment. By developing and refining a survey, researchers hope to gather insights to help other survivors make informed decisions about cancer treatments and family planning. The trial involves participating in focus groups or completing surveys online or over the phone. Women who have had early-stage ovarian, endometrial, cervical, or breast cancer and underwent fertility-preservation treatments might be a good fit. Participants should be comfortable communicating in either English or Spanish.

As an unphased trial, this study offers a unique opportunity for survivors to contribute to research that may improve future family planning resources for others.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on surveys and interviews rather than medical interventions.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to better understand infertility issues in women with gynecological and breast cancer through innovative methods like focus groups and surveys. Unlike traditional treatments that directly address infertility, this approach seeks to gather detailed patient feedback and experiences to develop more tailored and effective interventions in the future. By validating insights with both online and telephone surveys, the study can capture a wide range of perspectives, potentially leading to more comprehensive care strategies for these patients.

Who Is on the Research Team?

JA

Jose A Rauh-Hain

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

TELEPHONE SURVEY: Women in the California Cancer Registry
TELEPHONE SURVEY: Were diagnosed with early-stage ovarian (IA and IC), endometrial (IA), cervical (IA1-IB1), or breast cancer (I-III)
TELEPHONE SURVEY: Are 5-12 years post diagnosis between the years of 2007-2014
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Focus Group

Patients attend an audiotaped focus group over 90 minutes to provide feedback for survey development

1 day
1 visit (in-person)

Survey Validation

Patients complete an online survey over 15-30 minutes at baseline and 2 days later

2 days
Online

Telephone Survey

Patients complete a telephone survey

1 day
1 call

Follow-up

Participants are monitored for outcomes related to infertility and live births

Up to 3 years

What Are the Treatments Tested in This Trial?

Interventions

  • Healthcare Activity
  • Survey Administration

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Observational (focus group, survey)Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+